Author

Seunghwan Shim

Institution: Handok (South Korea)

Observed institutions: Korea University, Handok (South Korea)

ORCID: 0000-0003-1121-1746

Observed ORCID: 0000-0003-1121-1746

OpenAlex ID: A5002500984

Synthesis and Structure–Activity Relationships of Arylsulfonamides as AIMP2-DX2 Inhibitors for the Development of a Novel Anticancer Therapy

2020 · Aneesh Sivaraman, Dae Gyu Kim, et al. · Journal of Medicinal Chemistry · 23

NADPH oxidase inhibitor development for diabetic nephropathy through water tank model

2022 · Hye Eun Lee, Seunghwan Shim, et al. · Kidney Research and Clinical Practice · 10

Discovery of a NADPH oxidase inhibitor, (E)-3-cyclohexyl-5-(4-((2-hydroxyethyl)(methyl)amino)benzylidene)-1-methyl-2-thioxoimidazolidin-4-oneone, as a novel therapeutic for Parkinson's disease

2022 · Seunghwan Shim, Da Un Jeong, et al. · European Journal of Medicinal Chemistry · 7

Proceeding and future of novel drug development using Artificial Intelligence (AI)

2018 · Hyemi Kim, Hyejun Park, et al. · Institute of Life Science and Natural Resources · 1

Abstract 4218: Discovery and in vitro characterization of FGFR/HDAC dual inhibitors for FGFR-driven cancer

2025 · Chang-Hyun Yun, Sang-Heon Kim, et al. · Cancer Research

Palladium‐Catalyzed Synthesis of Pyrrolo[1,2‐α]Pyrazines From N‐Phenacyl Pyrrole‐2‐Carbonitriles and Aryl Boronic Acids

2024 · Hyejun Park, Seunghwan Shim, et al. · Journal of Heterocyclic Chemistry

대표적인 NADPH oxidase 저해제: 저해 방법, 효능, 그리고 다양한 질병에 대한 쓰임새

2022 · Seunghwan Shim, Yongseok Choi · Institute of Life Science and Natural Resources

Works count: 7

Citation count: 41

H-index: 3

I10-index: 2